NCT00268788View on ClinicalTrials.gov

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Multifocal Motor Neuropathy
Interventions
DRUG

Subcutaneous immunoglobulin

Individually dosed, given twice a week.

DRUG

Intravenous immunoglobulin

Individual dose and frequency

Trial Locations (1)

Unknown

Aarhus University Hospital, Department of Neyrology, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT00268788 - Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy | Biotech Hunter | Biotech Hunter